Addus HomeCare Corporation (NASDAQ:ADUS) Receives $142.57 Average Price Target from Brokerages

Addus HomeCare Corporation (NASDAQ:ADUS) has been given a consensus rating of “Buy” by the eight ratings firms that are covering the company, Marketbeat Ratings reports. Six analysts have rated the stock with a buy rating and two have given a strong buy rating to the company. The average 12-month price objective among analysts that have issued ratings on the stock in the last year is $142.57.

A number of equities analysts have commented on the company. Macquarie restated an “outperform” rating and set a $133.00 price objective on shares of Addus HomeCare in a research note on Tuesday, June 10th. Wall Street Zen upgraded Addus HomeCare from a “hold” rating to a “buy” rating in a research note on Sunday, June 29th. Finally, JMP Securities reiterated a “market outperform” rating and issued a $150.00 price target on shares of Addus HomeCare in a research note on Wednesday, July 16th.

Addus HomeCare Stock Up 1.2%

NASDAQ:ADUS opened at $108.71 on Friday. The company has a debt-to-equity ratio of 0.20, a quick ratio of 1.74 and a current ratio of 1.74. The company has a market cap of $2.00 billion, a PE ratio of 24.54, a PEG ratio of 1.52 and a beta of 0.81. Addus HomeCare has a 52-week low of $88.96 and a 52-week high of $136.72. The stock has a 50-day simple moving average of $112.35 and a 200 day simple moving average of $109.68.

Addus HomeCare (NASDAQ:ADUS) last released its quarterly earnings data on Monday, May 5th. The company reported $1.42 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.33 by $0.09. Addus HomeCare had a return on equity of 9.23% and a net margin of 6.52%. The company had revenue of $337.71 million during the quarter, compared to analysts’ expectations of $341.66 million. During the same period last year, the firm posted $1.21 earnings per share. The business’s revenue was up 20.3% on a year-over-year basis. On average, sell-side analysts expect that Addus HomeCare will post 4.59 EPS for the current fiscal year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Michael D. Wattenbarger sold 2,045 shares of the stock in a transaction on Tuesday, May 27th. The stock was sold at an average price of $115.00, for a total value of $235,175.00. Following the transaction, the executive vice president owned 7,796 shares of the company’s stock, valued at $896,540. This represents a 20.78% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 4.60% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the stock. Capital Research Global Investors purchased a new stake in shares of Addus HomeCare during the fourth quarter worth about $51,149,000. American Century Companies Inc. boosted its holdings in shares of Addus HomeCare by 695.8% during the fourth quarter. American Century Companies Inc. now owns 284,346 shares of the company’s stock worth $35,643,000 after purchasing an additional 248,613 shares during the period. Nuveen LLC purchased a new stake in shares of Addus HomeCare during the first quarter worth about $16,155,000. GAMMA Investing LLC boosted its holdings in shares of Addus HomeCare by 10,307.8% during the first quarter. GAMMA Investing LLC now owns 130,930 shares of the company’s stock worth $12,948,000 after purchasing an additional 129,672 shares during the period. Finally, Bank of America Corp DE boosted its holdings in shares of Addus HomeCare by 273.6% during the fourth quarter. Bank of America Corp DE now owns 175,070 shares of the company’s stock worth $21,945,000 after purchasing an additional 128,211 shares during the period. 95.35% of the stock is owned by institutional investors.

Addus HomeCare Company Profile

Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. The company operates through three segments: Personal Care, Hospice, and Home Health.